Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Am Geriatr Soc. 2011 Nov;59 Suppl 2:S282-8. doi: 10.1111/j.1532-5415.2011.03691.x.

Pilot randomized trial of donepezil hydrochloride for delirium after hip fracture.

Author information

  • 1Division of General Medicine and Primary Care, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. emarcant@bidmc.harvard.edu

Abstract

OBJECTIVES:

To determine whether donepezil hydrochloride can reduce the prevalence and severity of delirium in older adults undergoing hip fracture repair.

DESIGN:

Pilot double-masked randomized placebo-controlled trial.

SETTING:

Large academic medical center.

PARTICIPANTS:

Sixteen individuals aged 70 and older with hip fracture.

INTERVENTION:

Donepezil 5 mg or placebo was randomly allocated and initiated within 24 hours of surgery, preoperatively or postoperatively. Daily treatment was continued for 30 days or until side effects or the clinical situation required termination.

MEASUREMENTS:

All outcomes were ascertained masked to treatment status. Information on drug tolerability and safety was obtained from the participant, nurse, and medical record. Delirium presence and severity were measured during daily hospital interviews and at 2, 4, and 6 weeks after surgery after a standardized assessment using the Confusion Assessment Method (CAM) and the Memorial Delirium Assessment Scale (MDAS).

RESULTS:

Participants in the donepezil and placebo arms had similar baseline characteristics. Participants in the donepezil arm experienced significantly more side effects. In longitudinal models, there were no significant differences between the donepezil and placebo arms with regard to delirium presence over time (odds ratio = 0.9, 95% confidence interval (CI) = 0.4-2.3) or delirium severity over time (effect size = -0.2 on 30-point MDAS scale, 95%CI = -1.5-1.2).

CONCLUSION:

Participants randomized to donepezil had no significant improvement in delirium presence or severity but experienced more side effects. Overall, sufficient evidence was not found from this pilot study to warrant a definitive Phase III trial.

© 2011, Copyright the Authors Journal compilation © 2011, The American Geriatrics Society.

PMID:
22091574
[PubMed - indexed for MEDLINE]
PMCID:
PMC3233977
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Blackwell Publishing Icon for PubMed Central
    Loading ...
    Write to the Help Desk